We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Johnson & Johnson
JNJ
$635B
| $5.45M | 0.08% |
39,160
+18,180
| +87% | +$2.52M |
|
|
P
327
Everpure Inc
P
$24.8B
| $5.45M | 0.08% |
357,096
+95,830
| +37% | +$1.87M |
|
|
SBNY
328
DELISTED
Signature Bank
SBNY
| $5.45M | 0.08% |
+45,117
| New | +$5.58M |
|
329
Builders FirstSource
BLDR
$7.84B
| $5.41M | 0.07% |
320,686
+96,600
| +43% | +$1.44M |
|
|
INST
330
DELISTED
Instructure, Inc.
INST
| $5.38M | 0.07% |
126,601
-33,580
| -21% | -$1.45M |
|
331
Devon Energy
DVN
$51.9B
| $5.37M | 0.07% |
188,340
-19,850
| -10% | -$590K |
|
332
Sonos
SONO
$1.75B
| $5.36M | 0.07% |
472,725
-104,000
| -18% | -$1.14M |
|
333
SPS Commerce
SPSC
$2.25B
| $5.32M | 0.07% |
104,162
-43,786
| -30% | -$2.28M |
|
334
Five Below
FIVE
$11.2B
| $5.32M | 0.07% |
+44,285
| New | +$5.83M |
|
335
Masco
MAS
$16B
| $5.3M | 0.07% |
135,110
-26,880
| -17% | -$1.04M |
|
|
RPAI
336
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $5.27M | 0.07% |
447,786
-159,010
| -26% | -$1.95M |
|
337
Hyster-Yale Materials Handling
HY
$593M
| $5.25M | 0.07% |
95,092
+7,810
| +9% | +$436K |
|
338
Eli Lilly
LLY
$1.07T
| $5.18M | 0.07% |
46,777
-330
| -0.7% | -$38.9K |
|
339
Comfort Systems
FIX
$61B
| $5.14M | 0.07% |
100,749
+8,740
| +9% | +$450K |
|
340
Yum China
YUMC
$14.9B
| $5.13M | 0.07% |
111,020
-55,260
| -33% | -$2.4M |
|
|
FSCT
341
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.13M | 0.07% |
151,432
+140
| +0.1% | +$5.14K |
|
|
LNW
342
DELISTED
Light & Wonder
LNW
| $5.08M | 0.07% |
256,564
-15,690
| -6% | -$325K |
|
343
Edison International
EIX
$30.7B
| $5.07M | 0.07% |
75,135
+9,410
| +14% | +$584K |
|
344
Theravance Biopharma
TBPH
$874M
| $5.06M | 0.07% |
309,873
+41,060
| +15% | +$832K |
|
|
TOWR
345
DELISTED
Tower International, Inc.
TOWR
| $5M | 0.07% |
256,626
+23,060
| +10% | +$478K |
|
|
NGHC
346
DELISTED
National General Holdings Corp
NGHC
| $4.92M | 0.07% |
214,674
+155,607
| +263% | +$3.71M |
|
|
ARGO
347
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $4.91M | 0.07% |
66,312
+14,690
| +28% | +$1.08M |
|
|
PSDO
348
DELISTED
Presidio, Inc. Common Stock
PSDO
| $4.9M | 0.07% |
358,498
+55,250
| +18% | +$778K |
|
349
Enanta Pharmaceuticals
ENTA
$372M
| $4.89M | 0.07% |
+58,004
| New | +$5.22M |
|
|
DCH
350
Dauch Corp
DCH
$1.3B
| $4.89M | 0.07% |
383,012
+269,023
| +236% | +$3.5M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.